Emi-Le generated durable responses and encouraging PFS with manageable safety in patients with aggressive adenoid cystic carcinoma. @harvardmed.bsky.social @danafarber.bsky.social @ascocancer.bsky.social #ASCO26 #hncsm #oncology
www.onclive.com/view/emiltat...
Emi-Le generated durable responses and encouraging PFS with manageable safety in patients with aggressive adenoid cystic carcinoma.
www.onclive.com
OncLive